US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Amtrak train hits pickup truck in upstate New York, 3 dead including child
NEW YORK (AP) — A child was among the three victims killed when a passenger train hit a pickup truck2024-05-21Wealthy residents are fleeing LA, San Francisco and Orange County to little
Affordable real estate in Cali city hotspots is hard to come by - so much so that wealthy citizens a2024-05-21North Korea says it tested 'super
SEOUL, South Korea (AP) — North Korea said Saturday it tested a “super-large” cruise missile warhead2024-05-21Mexican police investigate a man as a possible serial killer
MEXICO CITY (AP) — Mexico City police said late Friday they are investigating a murder suspect as a2024-05-21California congressman urges closer consultation with tribes on offshore wind
A congressman who represents California’s north coast has sent a letter to federal regulators asking2024-05-21Felix Rosenqvist career turnaround continues as Swede gives Meyer Shank Racing 1st IndyCar pole
LONG BEACH, Calif. (AP) — Felix Rosenqvist’s career turnaround continued Saturday when the Swede won2024-05-21
atest comment